Killion Center for Neurodegeneration and Experimental Therapeutics

Researchers at UAB have discovered a surprising modification that could make an emerging therapy for frontotemporal dementia (FTD) more effective, potentially helping guide the next generation of treatments for a devastating disease that currently has no cure.

$10 million endowment to support Parkinson’s, Alzheimer’s, Huntington’s and ALS research and education.

In October, UAB announced a $5 million gift to establish the James Milton and Sallie R. Johnson Fund to Support Alzheimer’s Disease Research in the Department of Neurology and the UAB Center for Neurodegeneration and Experimental Therapeutics.